|
ヒグチ リヨウタ
Higuchi Riyouta
樋口 亮太 所属 医学部 医学科（附属八千代医療センター） 職種 講師 |
|
| 論文種別 | 原著 |
| 言語種別 | 英語 |
| 査読の有無 | 査読なし |
| 表題 | Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis. |
| 掲載誌名 | 正式名：Journal of hepato-biliary-pancreatic sciences 略 称：J Hepatobiliary Pancreat Sci ISSNコード：(1868-6982)1868-6974(Linking) |
| 掲載区分 | 国内 |
| 巻・号・頁 | 25(1),pp.3-16 |
| 著者・共著者 | GOMI Harumi,Solomkin Joseph S,Schlossberg David,OKAMOTO Kohji,TAKADA Tadahiro,Strasberg Steven M,UKAI Tomohiko,ENDO Itaru,IWASHITA Yukio,HIBI Taizo,Pitt Henry A,MATSUNAGA Naohisa,TAKAMORI Yoriyuki,UMEZAWA Akiko,ASAI Koji,SUZUKI Kenji,Han Ho-Seong,Hwang Tsann-Long,MORI Yasuhisa,Yoon Yoo-Seok,Huang Wayne Shih-Wei,Belli Giulio,Dervenis Christos,YOKOE Masamichi,KIRIYAMA Seiki,ITOI Takao,Jagannath Palepu,Garden O James,MIURA Fumihiko,de Santibañes Eduardo,SHIKATA Satoru,NOGUCHI Yoshinori,WADA Keita,HONDA Goro,Supe Avinash Nivritti,YOSHIDA Masahiro,MAYUMI Toshihiko,Gouma Dirk J,Deziel Daniel J,Liau Kui-Hin,Chen Miin-Fu,Liu Keng-Hao,Su Cheng-Hsi,Chan Angus C W,Yoon Dong-Sup,Choi In-Seok,Jonas Eduard,Chen Xiao-Ping,Fan Sheung Tat,Ker Chen-Guo,Giménez Mariano Eduardo,KITANO Seigo,INOMATA Masafumi,MUKAI Shuntaro,HIGUCHI Ryota,HIRATA Koichi,INUI Kazuo,SUMIYAMA Yoshinobu,YAMAMOTO Masakazu |
| 発行年月 | 2018/01 |
| 概要 | Antimicrobial therapy is a mainstay of the management for patients with acute cholangitis and/or cholecystitis. The Tokyo Guidelines 2018 (TG18) provides recommendations for the appropriate use of antimicrobials for community-acquired and healthcare-associated infections. The listed agents are for empirical therapy provided before the infecting isolates are identified. Antimicrobial agents are listed by class-definitions and TG18 severity grade I, II, and III subcategorized by clinical settings. In the era of emerging and increasing antimicrobial resistance, monitoring and updating local antibiograms is underscored. Prudent antimicrobial usage and early de-escalation or termination of antimicrobial therapy are now important parts of decision-making. What is new in TG18 is that the duration of antimicrobial therapy for both acute cholangitis and cholecystitis is systematically reviewed. Prophylactic antimicrobial usage for elective endoscopic retrograde cholangiopancreatography is no longer recommended and the section was deleted in TG18. Free full articles and mobile app of TG18 are available at: http://www.jshbps.jp/modules/en/index.php?content_id=47. Related clinical questions and references are also included. |
| DOI | 10.1002/jhbp.518 |
| PMID | 29090866 |